聚结合双功能降解剂:癌症免疫治疗的新方法
Binbin Cheng1, Zhihua Kong2, Yaru Shi3
1Central Laboratory, Wenzhou Medical University Lishui Hospital, Lishui People's Hospital, Lishui, Zhejiang 323000, China; Laboratory Animal Center, Wenzhou Medical University, Wenzhou 325000, China; Hubei Key Laboratory for Kidney Disease Pathogenesis and Intervention, Hubei Engineering Research Center for Immunotherapy Drug Studies on Renal Tumors, Hubei Polytechnic University, Huangshi, Hubei 435003, China.
Journal of advanced research
|November 27, 2025
概括
研究人员开发了一种新型小分子SPOP9,可以有效降解PD-L1,克服目前治疗方法的局限性. 这种新的PD-L1降解剂在癌症免疫治疗中显示出有希望的临床前疗效.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药用化学 医学化学
背景情况:
- 目前的PD-L1降解剂面临着药理动力学和药理动力学限制.
- 需要新的降解平台来克服癌症免疫疗法的现有挑战.
研究的目的:
- 设计和合成针对PD-L1降解的新型双功能小分子.
- 使用E3结合酶SPOP来创建创新的PD-L1降解剂.
- 评估这些降解剂在癌症免疫治疗中的潜力.
主要方法:
- 合成基于SPOP的双功能小分子.
- 通过使用HTRF和西布洛特评估PD-L1抑制和降解.
- 通过机理学研究证实了三元复合体的形成.
- 在B16-F10模型中评估体内药理动力学和抗瘤疗效.
主要成果:
- 化合物SPOP9显示出强大的PD-L1抑制和降解.
- SPOP9与PD-L1和SPOP形成了一个稳定的三元复合体.
- 在体内,SPOP9表现出良好的生物可用性和显著的瘤减少.
- SPOP9激活了瘤免疫微环境,并降低了PD-L1.1的调节.
结论:
- SPOP9是第一个SPOP结合的双功能PD-L1降解剂.
- SPOP9显示出有希望的临床前疗效和有利的药理动力学.
- 作为一种潜在的癌症免疫治疗剂,SPOP9需要进一步研究.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Vaccines
932
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
932
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K


